Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin vs Levofloxacin for H. pylori in COVID-19 Era
NCT05035186Completed
- Sponsor
- Alexandria University
- Start
- Mar 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in Helicobacter pylori infection comparing Clarithromycin Regimen with Levofloxacin Regimen (2 arms). Primary endpoint: H. pylori eradication rates. Started Mar 2021; status: completed.
02
Drugs
clarithromycinlevofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05035186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05035186.